Clinical trial

Degarelix Neo-Adjuvant Radical Prostatectomy Trial

NCT01674270

StatusCOMPLETED

Study typeINTERVENTIONAL

Start date2012-08-01

PhasePHASE2

Study timeline

Study start (unknown)2012-08-01Date precision: month

Registry last updated2015-12-22

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Prostate Cancerunresolved

Interventions

DegarelixDRUG · verified · RxNorm: degarelix

CasodexDRUG · verified · RxNorm: Casodex

LHRH AgonistDRUG

Sponsors & collaborators

University Health Network, Torontolead sponsor

Mapped research locations

TorontoOntario, Canada1 VancouverBritish Columbia, Canada1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT01674270 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.